Yield10 Bioscience inc (YTEN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access YTEN Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Yield10 Bioscience inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent0.73
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.47
Total Current Assets1.20
Equipment/Property/Plant Net0.43
Long-term investments0.01
Other Assets, Noncurrent1.33
Operating Lease Right Of Use Asset1.30
Total Assets2.97
Liabilities
Accounts Payable, Current AC2.37
Accrued Liabilities, Current AC1.83
Convertible Notes Payable, Current NO1.00
Other Liabilities, Current0.68
Deferred Revenue, Current DE1.80
Total Current Liabilities7.67
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.45
Other liabilities, Noncurrent1.09
OperatingLeaseLiabilityNoncurrent1.09
Operating Lease Liability Current0.68
Total Liabilities9.21
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock413.88
Retained Earnings / Accumulated Deficit-419.86
Other Equity-0.26
Common Stockholder's Equity-6.24
Total Stockholder's Equity-6.24
Liabilities & Stockholder's Equity2.97
4 historic quarters locked

Sign in to unlock the full Yield10 Bioscience inc balance sheet history.

About Yield10 Bioscience Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001121702-24-000065

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.